Ahead, which sold medication for treating ADHD onine, is shutting down, the company announced on its website. Founded in 2019, the San Francisco-based startup had raised $9 million in funding from telehealth company Truepill, according to financial data firm PitchBook. News of Ahead’s shut down was first reported by Bloomberg . The company is the second behavioral health startup to fold this...
Get access to exclusive coverage
Read deeply reported stories from the largest newsroom in tech.
The Weekend Crypto Startups
Truth or Consequences: Would You Take an AI-Powered Polygraph Test to Prove You Hadn't Cheated on a Spouse?
Hi, welcome to your Weekend! Even before the Supreme Court’s earth-shaking rulings this week that struck down states’ gun restrictions and ended women's right to an abortion, Americans were losing faith in the highest court in the land. On Thursday, Gallup reported that trust in the Supreme Court has never been lower, with only 25% of Americans responding that they had a great deal of...
Congressional Report Says Robinhood Understated Liquidity Problems During Meme Stock Craze
Zendesk Agrees to $10.2 billion Buyout Months After Rejecting Higher Bid
Meta Plans To Shut Down CrowdTangle Tool
Stay in the know
Receive a summary of the day's top tech news—distilled into one email.
Access on the go
View stories on our mobile app and tune into our weekly podcast.
Join live video Q&A’s
Deep-dive into topics like startups and autonomous vehicles with our top reporters and other executives.
Enjoy a clutter-free experience
Read without any banner ads.
Recent Popular Stories
Opinion Venture Capital
What Venture Investors Get Wrong About China
For two decades, investors in China’s venture capital firms have looked for partners with an instinct for the “new economy.” And for two decades, the firms have posted high-flying returns primarily driven by winners in this fiercely competitive arena—including upstarts in budget appliances (Xiaomi), social media (ByteDance), ride hailing (Didi) and food delivery (Meituan)—that seemed to validate that approach.